Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study (Leukemia, (2020), 34, 9, (2333-2341), 10.1038/s41375-020-0758-4)

Sabine Kayser, Ramy Rahmé, David Martínez-Cuadrón, Gabriel Ghiaur, Xavier Thomas, Marta Sobas, Agnes Guerci-Bresler, Ana Garrido, Arnaud Pigneux, Cristina Gil, Emmanuel Raffoux, Mar Tormo, Norbert Vey, Javier de la Serna, Olga Salamero, Eva Lengfelder, Mark J. Levis, Pierre Fenaux, Miguel A. Sanz, Uwe PlatzbeckerRichard F. Schlenk, Lionel Adès, Pau Montesinos

Research output: Contribution to journalComment/debatepeer-review

Abstract

The article Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study, written by Sabine Kayser, Ramy Rahmé, David Martínez-Cuadrón, Gabriel Ghiaur, Xavier Thomas, Marta Sobas, Agnes Guerci-Bresler, Ana Garrido, Arnaud Pigneux, Cristina Gil, Emmanuel Raffoux, Mar Tormo, Norbert Vey, Javier de la Serna, Olga Salamero, Eva Lengfelder, Mark J. Levis, Pierre Fenaux, Miguel A. Sanz, Uwe Platzbecker, Richard F. Schlenk, Lionel Adès & Pau Montesinos, was originally published Online First without Open Access. After publication in volume 34, page 2333–2341, the author decided to opt for Open Choice and to make the article an Open Access publication.

Original languageEnglish (US)
Pages (from-to)3631
Number of pages1
JournalLeukemia
Volume35
Issue number12
DOIs
StatePublished - Dec 2021

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study (Leukemia, (2020), 34, 9, (2333-2341), 10.1038/s41375-020-0758-4)'. Together they form a unique fingerprint.

Cite this